Skip to main content
Off-Label PrescriptionPrescription Medicine

Oxybutynin for Hot Flashes

An off-label anticholinergic prescription (oxybutynin), approved for overactive bladder, that can reduce moderate to severe hot flashes.

Last verified Updated Sources

Oxybutynin for Hot Flashes (Prescription Medicine)

Method facts

Oxybutynin for Hot Flashes
Measured outcome
Recommended (limited evidence)
How long it lasts
Daily pill (ongoing)
Reversibility
Reversible
Used for
Hot flash & night sweat relief
How you get it
Telehealth Prescription
Cost
$11–$14 / monthlyInsurance coverage: Varies
Status
Off-Label Prescription

Outcome & guideline status

Recommended (limited evidence)

Recommended with limited evidence by the Menopause Society.

Simon 2016 phase 2 RCT of extended-release oxybutynin 15 mg daily (73 women) vs placebo (75 women): at week 12, 73% of the oxybutynin group rated their symptom improvement "much better" vs 26% with placebo. The trial reported mean changes in daily moderate to severe hot flashes (-9.48 vs -4.69 episodes) rather than a percentage reduction. NAMS 2023 Levels I-II recommendation.

The details

What the evidence says

How well it works, what to watch for, who should avoid it, and the studies behind it.

How it works in the body

Clinical class
Anticholinergic

Oxybutynin is an anticholinergic that blocks muscarinic acetylcholine receptors, including receptors in the brain, and can decrease sweating.

Side effects

  • Dry mouth (over 50% of users)
  • Constipation
  • Dizziness
  • Drowsiness

Who shouldn't use this

Talk to a clinician first if any of these apply

  • Uncontrolled narrow-angle glaucomaEye conditions that damage the optic nerve, most often because of increased pressure in the eye
  • Urinary retentionDifficulty emptying the bladder
  • Gastric retentionDelayed stomach emptying
  • Hypersensitivity to oxybutynin or any ingredientAn allergy or sensitivity to the medicine, device, or one of its ingredients
  • Severe gastrointestinal disease that slows gut motilitySevere digestive tract conditions that can be worsened by anticholinergic medicines

Clinical guidelines

Cost and insurance

Generic oxybutynin is inexpensive. Cash prices as of October 2026 (Drugs.com) start at about $11 for 60 tablets of 5 mg (5 mg twice a day for a month) and about $14 for 30 extended-release 15 mg tablets (15 mg once a day).

Insurance coverageVaries

What to know about Oxybutynin for Hot Flashes

How it works

Oxybutynin is a prescription drug approved for overactive bladder, but it is also used off-label for menopause hot flashes. It is an anticholinergic that blocks acetylcholine receptors, including in the brain, and can decrease sweating.

How well it works

A 2016 randomized controlled trial by Simon et al. found that 73% of women taking extended-release oxybutynin rated their symptom improvement “much better” at 12 weeks, compared to 26% with placebo. The NAMS 2023 position statement lists it as a Levels I-II recommendation.

Side effects and cautions

Oxybutynin is not FDA-approved for hot flashes, so this use is off-label. In the Simon 2016 trial, dry mouth affected over half of women taking oxybutynin. Other side effects include constipation, dizziness, and drowsiness. NAMS 2023 notes that long-term use of anticholinergics may be associated with cognitive decline, particularly in older people, and a review describes evidence that oxybutynin may increase the risk of dementia (Chancellor 2024 review). You should not take oxybutynin if you have uncontrolled narrow-angle glaucoma, urinary retention, gastric retention, or a known allergy to the drug.

Where to get it

You need a prescription from a clinician, such as your primary care provider. Generic oxybutynin is inexpensive. Check our provider directory for clinics near you.

1 product in this category

Specific branded items that use this method. Compare manufacturer details, active ingredients, and regulatory status.

Frequently asked questions

Sources (6)
  1. Research source: Midi Health — nonhormonal hot flash treatments (telehealth)
  2. Research source: Simon 2016 RCT of oxybutynin for hot flash severity (PMID 27760081)
  3. Research source: Chancellor MB et al. 2024, review of oxybutynin-associated cognitive impairment and dementia risk (PMID 38296001)
  4. Clinical guideline: NAMS 2023 Nonhormone Therapy Position Statement for hot flashes and night sweats
  5. Research source: DailyMed — oxybutynin chloride extended-release tablets FDA label (Ajanta Pharma USA)
  6. Research source: Drugs.com — oxybutynin price guide

How we verify